Breaking News

Kemwell Expands Capabilities in India

May 14, 2013

Adds analytical equipment and scientists for FTE contract

Kemwell Biopharma has expanded its analytical capabilities in India to service an FTE contract for a large, multinational pharma company. The new analytical lab is equipped with 10 HPLC's, one UPLC and nine dissolution apparatus and other analytical instruments. Kemwell will also employ 15 scientists dedicated to this project.
 
Ninad Deshpanday, president of R&D at Kemwell, said, "This project and lab expansion further reflects Kemwell's commitment to its customers. Kemwell has invested in a dedicated facility to meet the needs of this very important customer. The scope of the project includes method transfer, stability sample analyses and analytical method validation for various projects for the customer. We are actively looking to invest in and grow our development business."
 
Kemwell's R&D division employs more than 100 scientists and provides services from formulation development, analytical development and validation to clinical trial manufacturing.
blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.